Biomedical Research Facilities (C06 Clinical Trial Not Allowed) | PAR 19 128

Opportunity Information: Apply for PAR 19 128

The National Institutes of Health (NIH) grant opportunity "Biomedical Research Facilities (C06 Clinical Trial Not Allowed)" (Funding Opportunity Number PAR-19-128; CFDA 93.352) is designed to help U.S. academic institutions improve the physical infrastructure that supports biomedical research. Through this discretionary grant program, NIH is inviting eligible colleges and universities to request funding to either modernize existing biomedical research space or construct new facilities. The underlying purpose is not to fund a specific research study, but to strengthen an institution's overall capacity to carry out high-quality biomedical research by investing in the shared spaces, systems, and core resources that researchers rely on every day.

A central theme of the announcement is institution-wide benefit. NIH is looking for projects that address applicant-defined, campus-wide biomedical research needs rather than narrow, single-lab interests. The expectation is that the proposed facility work will create long-term improvements to the institution's research infrastructure, meaning the upgrades should have lasting value and broad utility for multiple research groups. The FOA specifically highlights modernization of core facilities and the development of other shared infrastructure used by an institution-wide research community. In practical terms, this points to projects such as renovating or building shared laboratory cores, developing centralized research support spaces, and improving facility capabilities that enable modern biomedical research programs to function more effectively and competitively.

Eligibility is focused on U.S.-based public and nonprofit private institutions of higher education. NIH explicitly encourages applications from both research-intensive universities and Institutions of Emerging Excellence in biomedical research across all U.S. geographic regions. This emphasis reflects NIH's stated view that a wide range of institutions contribute to national research capacity, and that strengthening infrastructure beyond traditionally dominant research hubs can benefit the broader biomedical enterprise. The announcement also calls out several categories of institutions as eligible applicants under the "other eligible applicants" umbrella, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISIs), Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), and Tribally Controlled Colleges and Universities (TCCUs). The inclusion of these groups signals a strong interest in supporting infrastructure that can expand opportunity and build sustainable research environments in diverse institutional settings.

There are clear restrictions related to foreign involvement. Non-domestic (non-U.S.) entities are not eligible to apply, and non-domestic components of U.S. organizations are also not eligible. In addition, foreign components, as defined by the NIH Grants Policy Statement, are not allowed under this FOA. In other words, the facility work supported by this program must be fully domestic and aligned with NIH policy limits on foreign participation.

From a funding standpoint, the instrument type is a grant under the health activity category, and the listed award ceiling is $8,000,000. The original closing date for the opportunity was March 4, 2019, and the FOA was created on December 20, 2018. Finally, the title includes "Clinical Trial Not Allowed," which indicates that the funding is not intended to support clinical trials; the focus is on facilities and infrastructure improvements that enable biomedical research broadly rather than trial implementation.

• The National Institutes of Health in the health sector is offering a public funding opportunity titled "Biomedical Research Facilities (C06 Clinical Trial Not Allowed)" and is now available to receive applicants.
• Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.352.
• This funding opportunity was created on 2018-12-20.
• Applicants must submit their applications by 2019-03-04. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
• Each selected applicant is eligible to receive up to $8,000,000.00 in funding.
• Eligible applicants include: Public and State controlled institutions of higher education, Private institutions of higher education, Others.

Apply for PAR 19 128

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal: